Compare Stocks

→ World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MIRA MIRA Pharmaceuticals	$0.89 +2.3%	$1.06	$0.76 ▼ $7.98	$13.15M	N/A	560,231 shs	15,601 shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MIRA MIRA Pharmaceuticals	-0.92%	+7.43%	-25.00%	-25.64%	+86,999,900.00%

World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MIRA MIRA Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MIRA MIRA Pharmaceuticals	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MIRA MIRA Pharmaceuticals	N/A	N/A	N/A	N/A	$0.30 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MIRA MIRA Pharmaceuticals	-$11.98M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	7/1/2024 (Estimated)

Latest MIRA, MCLS, MTMY, FLX, and UCG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/1/2024	Q4 2023	MIRA MIRA Pharmaceuticals	N/A	-$0.19	-$0.19	-$0.19	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MIRA MIRA Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MIRA MIRA Pharmaceuticals	N/A	8.71	8.71

Ownership

Institutional Ownership

Company	Institutional Ownership
MIRA MIRA Pharmaceuticals	35.16%

Insider Ownership

Company	Insider Ownership
MIRA MIRA Pharmaceuticals	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MIRA MIRA Pharmaceuticals	2	14.78 million	N/A	Not Optionable

MIRA, MCLS, MTMY, FLX, and UCG Headlines

Source	Headline
	From Novartis' turnaround to everything you should know about studying abroad, here are our top reads of the week forbesindia.com - April 20 at 2:13 AM
	MIRA Pharmaceuticals (MIRA) Price Target Decreased by 27.31% to 16.83 msn.com - April 17 at 3:12 PM
	ALS drug Relyvrio withdrawn from market after failed clinical trial ksbw.com - April 4 at 6:40 PM
	FDA clears first digital treatment for depression, but experts caution that research is still early msn.com - April 2 at 8:22 PM
	MIRA Pharmaceuticals Sees Positive Trial Results for Ketamir-2 marketwatch.com - April 2 at 3:12 PM
	Mira Pharmaceuticals Steps Closer To Ketamir-2 IND Submission After Positive Preclinical Results markets.businessinsider.com - April 2 at 3:12 PM
	MIRA Making Strides Toward Breakthrough Treatment finance.yahoo.com - April 2 at 3:12 PM
	Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission prnewswire.com - April 2 at 8:00 AM
	Kilitch Drugs (India) Share Price business-standard.com - March 29 at 3:22 PM
	‘Ninja,’ Twitch’s biggest streamer, diagnosed with skin cancer msn.com - March 28 at 2:17 PM
	Family Care Hospitals Share Price business-standard.com - March 28 at 2:17 PM
	Clarence Thomas and Samuel Alito dust off 150-year-old Comstock Act to target abortion rights msn.com - March 28 at 2:17 PM
	MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor prnewswire.com - March 21 at 11:04 AM
	There are ways to improve the London Stock Exchange crisis, but they’re not pretty ca.finance.yahoo.com - March 18 at 12:00 PM
	Mutual funds: 23% returns in five-year period; should you invest in the surging healthcare funds? economictimes.indiatimes.com - March 18 at 12:00 PM
	Baker Hill Nominated for Tech Company of the Year in TechPoint's 25th Annual Mira Awards finance.yahoo.com - March 12 at 9:54 AM
	Benchmarks trade lower; European mkt decline business-standard.com - March 11 at 9:20 AM
	ALS drug fails large clinical trial and may be withdrawn from market msn.com - March 8 at 6:41 PM
	Medical Marijuana-Focused Mira Pharmaceuticals Stock Surges After Neuropsychiatric Disorders Update - Here's Why msn.com - March 8 at 6:41 PM
	Why Is Mira Pharmaceuticals (MIRA) Stock Up 52% Today? investorplace.com - March 8 at 8:19 AM
	El Salvador -India strengthen ties: Adriana Mira unveils path to bilateral cooperation msn.com - March 1 at 10:26 AM
	Maternal mental health conditions drive climbing death rate in US, research says ca.finance.yahoo.com - February 23 at 9:38 AM
	This is how Shahid Kapoor wished his wife Mira on Valentine's Day bignewsnetwork.com - February 14 at 8:06 AM
	Future Market Insights Predicts Robust Growth for Fertility Test Market, CAGR of 7.9% from 2024 to 2034 prnewswire.co.uk - February 6 at 8:57 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Wall Street slips after dispiriting data on the economy, as Meta sinks
April 25, 2024 2:14 AM
View Stock market today: Wall Street slips after dispiriting data on the economy, as Meta sinks
Buy the Dip in Netflix Stock, It Won’t Last Long
April 19, 2024 8:32 AM
View Buy the Dip in Netflix Stock, It Won’t Last Long
Users Refuse to Give Up On Spotify, So Does Wall Street
April 24, 2024 6:05 AM
View Users Refuse to Give Up On Spotify, So Does Wall Street
Crane Stock's Quarter On-Track For a Bullish Year?
April 24, 2024 6:10 AM
View Crane Stock's Quarter On-Track For a Bullish Year?

All Headlines

Company Descriptions

MIRA Pharmaceuticals

NASDAQ:MIRA

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial